STAT3 and hepatocellular carcinoma: Moreover, STAT3 signaling was proved to inhibit the expression of activation receptor NKD2G on NKs and its corresponding ligands MICA/B on tumor cells, which could block the activation of NKs and result in failing immune surveillance in HCC (Figure 2).